Press Releases | Philochem

Dario Neri presented “Antibody-cytokine fusion proteins

by last | Mar 17, 2015 | 2015, Press Releases

Dario Neri presented “Antibody-cytokine fusion proteins: from the bench to the clinic” at 1st International Symposium for Medicinal Sciences organized by the Pharmaceutical Society of Japan (PSJ) in association with the 135th Annual Meeting of the PSJ...

Philogen was present at BIO-Europe Spring® Conference. Paris (France), 9th-11th March.

by last | Mar 9, 2015 | 2015, Press Releases

Philochem announced the publication in the prestigious journal Nature Chemistry of an article entitled ‘Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation’.

by last | Mar 3, 2015 | 2015, Press Releases

Philochem announced the publication in the prestigious journal Nature Chemistry of an article entitled ‘Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation’. This publication covers a novel strategy for...

Giulio Casi – presented “Arming disease-targeting ligands with cytokines and cytotoxic drugs” at World ADC Conference. Frankfurt (DE), 24th-25th February.

by last | Feb 24, 2015 | 2015, Press Releases

Dario Neri – presented “Immunocytokines for the Therapy of Cancer and of Chronic Inflammation” at Biochemical Pharmacology Discussion Group (NY Academy Sciences/Boehringer). NY (USA), 27th January.

by last | Jan 27, 2015 | 2015, Press Releases

Philogen announced Option and License Agreement with Pfizer Inc.

by last | Dec 22, 2014 | 2014, Press Releases, Scientific

Philogen announced Option and License Agreement with Pfizer Inc. to develop and commercialize multiple antibody drug conjugates and targeted nano particles. (see full press release). Siena (Italy), December 22nd, 2014.